Ardelyx, Inc. reported $451M of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $451M (to Q2 2026). Net income: −$56M, trailing twelve months to Q2 2026. Free cash flow: −$18M, trailing twelve months to Q2 2026. Operating margin: −9.2%, trailing twelve months to Q2 2026.

ARDXArdelyx, Inc.

Healthcare

$3.28-47% 1Y

$3.28

$3.2652 weeks$7.99

ARDX as reported

Ardelyx, Inc. reported $451M of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed.

$451M

Revenue, trailing twelve months · to Q2 2026 · +17% against the twelve months before

Net income: −$56M
Net income · −1.2% year on year · trailing twelve months to Q2 2026
Free cash flow: −$18M
Free cash flow · −68% year on year · trailing twelve months to Q2 2026
Operating margin: −9.2%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ARDX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$451M	+17%	Q2 2026
Net income	−$56M	−1.2%	Q2 2026
EPS	−$0.23	−0.00%	Q2 2026
Gross margin	94%	n/a	Q2 2026
Operating margin	−9.2%	n/a	Q2 2026
Net margin	−14%	n/a	Q2 2026
ROE	−37%	n/a	Q2 2026
ROA	−11%	n/a	Q2 2026
ROIC	−27%	n/a	Q2 2026
Free cash flow	−$18M	−68%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.